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Abstract  
Purpose: To retrospectively analyze the location of confluent hepatic fibrosis 
in relation to the portal and hepatic venous anatomy using multidetector 
computed tomography (CT) and to clarify the influence of the hepatic venous 
drainage on confluent fibrosis.  
Materials and Methods: The study population consisted of 879 patients 
diagnosed with cirrhosis: 539 men and 340 women (65.9 ± 10.6 years), 633 
patients with Child-Pugh class A, 161 with class B, and 85 with class C. The 
cause of cirrhosis was hepatitis C (n= 528) and hepatitis B (n= 122) virus 
infection, alcoholism (n= 114), and others (n= 115). The confluent fibrosis 
was diagnosed using CT images according to previous reports, and 
statistically analyzed (p<.05).  
Results: Thirty-five confluent fibrosis lesions in 30 patients (3.4%) were 
identified. The predictive factors were alcoholic cirrhosis (odds ratio, 7.25; 
p<.0001), Child-Pugh class C (odds ratio, 6.95; p<.0001), and Child-Pugh 
class B (odds ratio, 2.91; p<.0023). The confluent fibrosis was most 
frequently seen in the middle hepatic venous drainage area (n= 21), or at the 
boundary between the medial and anterior segments (n= 17), and each 
distribution of the location of confluent fibrosis was significantly unequal 
(p<.0001).   
Conclusion: Confluent fibrosis was most commonly located in the middle 
hepatic venous drainage area.   
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Liver fibrosis, a common feature of almost all causes of chronic liver disease, 
refers to the excess deposition of collagen, proteoglycans, and other 
macromolecules in the extracellular matrix in response to repetitive liver 
injury from various causes [1]. Liver fibrosis is considered to be irreversible, 
but is regarded as a dynamic process with potential for regression [2]. 
During the progression of fibrosis, the accumulation of proteins in the 
extracellular matrix promotes the formation of scars that bridge together 
across adjacent portal triads and central veins, and ultimately, hepatic 
fibrosis can be demonstrated on computed tomography (CT) or magnetic 
resonance (MR) imaging as fibrotic septa and bridges in patients with 
end-stage liver disease [2, 3].   
Confluent hepatic fibrosis is considered to be the most extreme stage of 
fibrosis and is occasionally encountered in patients with end-stage cirrhosis. 
It is demonstrated as broad fibrotic scars, and the imaging findings have 
been summarized as a focal, often wedge-shaped mass, with either overlying 
capsule retraction or focal flattening of the capsule, most often involving the 
anterior and medial segment, and less frequently the posterior segment [4, 
5]. Ohtomo et al [4] speculated that the mechanism of this change might be 
related to impaired portal microcirculation, although the intrahepatic portal 
venous system was grossly patent. After the original reports, several cases 
showing similar locations of confluent fibrosis were described [6-10]. 
However, it has not been clarified why the fibrosis of diffuse liver disease, a 
basically diffuse process, appears preferentially in these particular segments 
as confluent fibrosis.  
It is widely recognized that a decreased or reversed flow of the portal blood 
supply can be seen when the hepatic venous flow is obstructed [11, 12]. As a 
result, parenchymal changes similar to those evoked by portal venous flow 
blockage can be expected, resulting in marked fibrosis in the area with 
hepatic venous flow disturbance. Furthermore, in cirrhosis, hepatic venous 
flow disturbance due to the compression and deformity caused by 
regenerative nodules and fibrosis is one of the most important causes of 
portal hypertension [13]. In addition, Ozaki et al [14] previously reported 
that selective atrophy of middle hepatic venous (MHV) drainage area 
commonly occurs in hepatitis C-related liver cirrhosis (mostly macronodular 
cirrhosis). Based on these facts and observations, we speculated that 
disturbed hepatic venous drainage might be related to the development of 
confluent fibrosis.  
In this study, we retrospectively analyzed the location of confluent fibrosis 
in relation to the portal venous supply and hepatic venous drainage using 
multidetector CT so as to clarify the influence of the hepatic venous drainage 
on confluent fibrosis.  
 
Materials and Methods   
Institutional approval was obtained for this retrospective study, and 
informed consent to use the medical records and materials for this study was 
obtained from all patients.  
 
Patients  
Between October 2002 and August 2009, 1327 consecutive patients with 
cirrhosis at our institution who underwent upper abdominal dynamic CT to 
evaluate the stage of their chronic liver injury and to detect any associated 
hepatocellular carcinoma were investigated. There were 854 men and 473 
women with a mean age of 66.2 ± 10.7 years (range, 7-90 years). Four 
hundred and forty-eight patients were excluded because of difficulty in 
accurately evaluating the morphology of the liver or the locations based on 
the portal or hepatic vein due to a history of transcatheter arterial 
chemoembolization and/or radiofrequency ablation (n= 230), severe 
deformation or hepatomegaly due to advanced tumor (n= 113), history of 
hepatectomy (n= 69), an interruption of the scan because of the development 
of a contrast material-related allergy (n= 20), history of living donor liver 
transplantation (n= 9), or history of transjugular intrahepatic portosystemic 
shunt (n= 7). The final study population consisted of 879 patients; 539 men 
and 340 women with a mean age of 65.9 ± 10.6 years (range, 7-89 years), 633 
patients with Child-Pugh class A cirrhosis, 161 patients with Child-Pugh 
class B cirrhosis and 85 patients with Child-Pugh class C cirrhosis. The 
cause of cirrhosis was hepatitis C virus infection (n= 528), hepatitis B virus 
infection (n= 122), alcoholism (n= 114), unknown etiology (n= 36), primary 
biliary cirrhosis (PBC) (n= 31), non-alcoholic steatohepatitis (NASH) (n= 24), 
autoimmune hepatitis (AIH) (n= 15), hepatitis C and B virus infection (n= 3), 
Budd-Chiari syndrome (n= 3), hepatitis C virus infection and alcoholism (n= 
2), or Wilson’s disease (n= 1). More details are noted in Table 1. Diagnosis of 
cirrhosis was based on histology in 626 patients: percutaneous liver biopsy 
(n= 591), hepatectomy for hepatocellular carcinoma (n= 32), and liver 
transplantation (n= 3). The histological data were adjunctively referred to in 
the patients who underwent hepatectomy or liver transplantation if 
confluent fibrosis was detected. In the remaining 253 patients [hepatitis C 
virus infection (n= 187), hepatitis B virus infection (n= 51), alcoholism (n= 
12), and Budd-Chiari syndrome (n= 3)], a clinical diagnosis of cirrhosis was 
based on a combination of imaging findings (ultrasound, CT, and/or MR 
imaging) [15-17], upper gastrointestinal endoscopic findings (esophageal 
and/or gastric varices), abnormal laboratory data (prolonged prothrombin 
time, decreased platelet count, abnormal serum albumin and cholesterol 
levels, increased total bilirubin and γ-globulin levels, specific antinuclear 
antibody, and so on), and clinical presentation (cutaneous spider angiomas, 
abdominal subcutaneous portosystemic shunts, ascites, and hepatic 
encephalopathy, and so on) or clinical history (drinking history, other 
disease). Most of these patients were not candidates for liver biopsy because 
of advanced end-stage cirrhosis or refusal of biopsy.  
 
Imaging Techniques  
Abdominal dynamic CT images were obtained with a LightSpeed Ultra 16 
(GE Medical Systems, USA) (n= 723) or with a LightSpeed VCT 64 (GE 
Medical Systems, USA) (n= 156), which was introduced in March 2008. 
Images obtained with the LightSpeed Ultra 16 were acquired through the 
liver in a craniocaudal direction with a 1.5×16 beam collimation. Other CT 
parameters were as follows: 300-350 mAs; 120 kVp; detector collimation, 2.5 
mm; table speed, 14 mm per rotation; gantry rotation time, 0.5 s; 
reconstruction section thickness of 2.5 mm and a reconstruction interval of 
2.5 mm. Before each scan, patients were instructed to breathe in and hold 
during the scanning. Following precontrast CT, a dynamic contrast study 
was performed 30s (arterial phase), 60s (portal phase), and 120s 
(equilibrium-phase) after the completion of an intravenous injection of 600 
mgI/kg of nonionic contrast material (Iomeron 350 [Eisai, Tokyo, Japan]) at 
a rate of 3-4 mL/s. Using these acquisition parameters, the approximate 
mean volume CT dose index was 18.2 mGy and the dose length product was 
550.1 mGy-cm per scan.  
Images obtained with a LightSpeed VCT 64 were acquired through the liver 
in a craniocaudal direction with a 0.625 × 64 beam collimation. Other CT 
parameters were as follows: Auto mA (GE Healthcare; 10–700 mA, Noise 
Index of 8.0); the remainder was the same as noted above. Following 
precontrast CT, a dynamic contrast study was performed using the Smart 
Prep option (automated software with scan triggering; GE Medical Systems) 
and 600 mgI/kg of nonionic contrast material (Iomeron 350) was 
administered for thirty seconds. The arterial phase scanning was initiated 
just after a 200 Hounsfield unit enhancement threshold was achieved in the 
aorta at the level of the celiac artery. The portal and equilibrium-phase 
scanning was performed at 35-second and 115-second delays, respectively, 
from the time of initiation of the arterial phase scanning. Using these 
acquisition parameters, the approximate mean volume CT dose index was 
18.7 mGy and the dose length product was 570.3 mGy-cm per scan.  
 
Definition of confluent hepatic fibrosis  
The presence of confluent fibrosis was evaluated based on the original 
report of Ohtomo et al [4]. The imaging findings are as follows: the shape is 
wedge-shaped, peripheral and band-shaped lesions remote from the central 
portion of the liver, or segmental involvement. On precontrast CT, it usually 
shows hypoattenuation relative to the surrounding liver parenchyma. The 
lesion might be isoattenuating when the density of surrounding liver 
parenchyma is lower than usual. On the arterial phase, it may show a 
variety of enhancement patterns on CT and MR imaging [6, 17]. A variable 
degree of delayed enhancement is commonly seen on the equilibrium-phase 
[6, 18]. The lesions show varying degrees of parenchymal shrinkage of the 
involved area and capsule retraction. No calcification or dilatation of the 
intrahepatic biliary ducts is seen. The portal trunk and major hepatic vein 
including its major branches were confirmed to be patent to exclude 
morphological changes due to thrombus or tumor invasion. CT images in all 
879 patients were interpreted and the presence of confluent fibrosis was 
identified retrospectively by 3 experienced abdominal radiologists (two with 
more than 10 and the other with more than 30 years of experience each in 
liver imaging). All images were analyzed subjectively and independently by 
these 3 radiologists.      
 
Definition of hepatic segments  
In cases with confluent fibrosis, its location was categorized according to 
the hepatic segmentation defined by the Couinaud system [19]; lateral, 
medial, anterior, and posterior segments, and caudate lobe. The portal vein 
was traced from the main portal trunk to peripheral branch using a viewer 
(EV Insite Version 2.10.7.91, PSP Corporation, Tokyo, Japan) during the 
portal phase of axial CT, and the location was categorized based on the 
branches supplying the lesion.  
The location of confluent fibrosis was also categorized according to the 
hepatic venous branches. They were classified as left, middle, and right 
hepatic venous (LHV, MHV, and RHV) drainage areas [20, 21]. The hepatic 
veins were traced from the point of convergence with the inferior vena cava, 
or the point of convergence of the MHV and LHV up to the hepatic surface 
during the portal phase or the equilibrium-phase of axial CT using the 
viewer, and the drainage branches to the lesion were identified. The reached 
branch of the major hepatic vein was defined as each hepatic venous 
drainage area. The vessels and their location were identified by the same 
three radiologists in consensus. Representative cases of confluent fibrosis are 
shown in Figures 1 and 2.   
 
Statistical analysis  
To assess interobserver variability, k statistics were applied. A k value of 
up to 0.20 was considered to indicate slight agreement; a k value of 0.21–0.40, 
fair agreement; a k value of 0.41–0.60, moderate agreement; a k value of 
0.61–0.80, substantial agreement; and a k value of 0.81 or greater, almost 
perfect agreement. The Mann-Whitney U test was used to compare the 
distribution of age. Chi-square test or Fisher’s exact test (if the observed 
frequency of cases was less than five) was used for categorical variables (sex, 
Child-Pugh classification, and cause of cirrhosis). The cause was categorized 
as alcoholism or others for analysis using Fisher's exact test, because the 
numbers of cases with confluent fibrosis due to each cause of cirrhosis were 
too few to obtain reliable statistical results. Stepwise multiple logistic 
regression analysis by means of forward selection was used to identify 
significant factors of confluent hepatic fibrosis. The significant variables in 
the univariable analyses were included. The cause was categorized as 
alcoholism or others for the same reason mentioned above. The chi-square 
test for goodness-of-fit with Yates' continuity correction was used to access 
the distribution of the location of the confluent fibrosis based on the portal 
blood supply or hepatic venous drainage. Cases with the lesions infrequently 
observed were categorized as others if needed. All analyses were performed 
with statistical software (Dr. SPSS II for Windows, version 11.0.1 J; SPSS, 
Chicago, Ill), and p < .05 was considered statistically significant.  
Thirty-five focal confluent fibrosis lesions in 30 patients (3.4%) were 
identified. Twenty-five patients (83.3%) had a single lesion, 5 (16.7%) had 
two lesions, and no patient had three or more lesions. In three patients, it 
was confirmed histologically by liver transplantation and in one by partial 
hepatectomy for hepatocellular carcinoma at a different location. They were 
24 men and 6 women (Fisher's exact test, p=0.036) with a mean age of 62.6 ± 
10.3 years (range, 44-84 years) (Mann-Whitney U test, p=0.039). The cause 
of the confluent fibrosis was alcoholism (n= 17/114) (14.9%), AIH (n= 1/15) 
(6.7%), PBC (n=1/31) (3.2%), unknown etiology (n=1/36) (2.8%), or hepatitis 
C virus infection (n= 10/528) (1.9%). They were classified as Child-Pugh class 
A cirrhosis (n=11/633) (1.7%), Child-Pugh class B cirrhosis (n=9/161) (5.6%), 
and Child-Pugh class C cirrhosis (n=10/85) (11.8%). Stepwise multivariate 
logistic regression analysis included the variables for all clinical data. The 
results showed that the significant predictive factors of confluent fibrosis 
were alcoholic cirrhosis (odds ratio, 7.251; p < 0.001; 95% confidence interval 
(CI), 3.366-15.619), Child-Pugh class C (odds ratio, 6.946; p < 0.001; 95% CI, 
2.765-17.446), and Child-Pugh class B (odds ratio, 2.914; p = 0.023; 95% CI, 
1.161-7.312) (Table 2). The location of the lesions based on the portal venous 
blood supply according to Couinaud’s segmental system was as follows: the 
medial and anterior segments, which was precisely expressed as the 
boundary between the medial and anterior segments based on CT images 
(n= 17) (Figures 1 and 2), anterior segment (n= 7), anterior and posterior 
segments (n= 3), lateral segment (n= 3), medial, anterior and posterior 
segments (n= 2), medial segment (n= 1), posterior segment (n= 1), and lateral, 
medial, and anterior segments (n= 1). No lesion involved the caudate lobe 
(Table 3). The goodness-of-fit test showed the unequal distribution of the 
location of confluent fibrosis (χ25 = 28.26, P < .0001; the last three locations 
[n=1] were categorized as others).  
The location based on the hepatic venous drainage was as follows: MHV 
drainage area (n= 21) (Figures 1 and 2), RHV drainage area (n= 8), LHV 
drainage area (n= 3), and MHV and RHV drainage areas (n= 3) (Table 4). 
The goodness-of-fit test showed the unequal distribution of the location of 
confluent fibrosis (χ23 = 24.77, P < .0001).       
 
Discussion   
In this study, we accessed confluent hepatic fibrosis in patients with 
cirrhosis in relation to the portal and hepatic venous anatomy. The results 
showed confluent fibrosis in 3.4% of patients with cirrhosis. The lesions were 
most commonly seen in the patients with advanced and/or alcoholic cirrhosis, 
and in MHV drainage area in terms of hepatic venous drainage or at the 
boundary between medial and anterior segments in terms of portal venous 
supply. In general, the MHV receives blood mainly from the medial segment 
and ventral portion of the anterior segment [22], and the most common site 
of confluent fibrosis was confirmed to be within the MHV drainage area.  
The prevalence of confluent fibrosis in our study (3.4%, 30 of 879 patients) 
is lower than that in Ohtomo’s study [4], thought to be due to the difference 
in the stage of the cirrhosis. Two-thirds of the patients were classified as 
Child-Pugh class A in our study, and this study population consisted largely 
of less advanced cirrhosis as compared with the patients with relatively 
advanced cirrhosis who underwent liver transplantation in Ohtomo’s study.  
The developmental mechanism of confluent fibrosis has been speculated to 
be related to impaired portal microcirculation [4, 22]. It is based on the fact 
that decreased or absent portal blood supply was detected on CT during 
arterial portography [23], and that the reduction of portal flow resulted in 
loss of the volume of hepatocytes with increased fibrosis and segmental 
atrophy of the liver [24]. However, confluent fibrosis was located most 
commonly at the boundary between the anterior and medial segments. The 
simultaneous reduction of portal blood supply in both the medial and ventral 
portions of the anterior segment may be difficult to explain based on a 
hypothetical disproportion of the portal blood supply. Other factors such as 
so-called streaming of the portal blood flow with the predominant splenic 
venous blood containing relatively large levels of insulin and other 
pancreatic hormones supplying the lateral segment [25], or the expected 
turbulent hepatopetal portal flow at the umbilical portion observed on 
ultrasound resulting in reduced portal flow to the medial segment [26] may 
also be implicated. 
On the other hand, it is well known that when hepatic venous flow is 
obstructed, the portal flow in the obstructed segment is markedly reduced or 
even reversed resulting in the same hemodynamic conditions as in 
intrahepatic portal venous occlusion [11, 12]. Indeed, the intrahepatic 
venous flow obstruction also induces marked atrophy of the obstructed liver 
parenchyma as commonly observed in Budd-Chiari syndrome [27].  
The hepatic veins, unlike portal veins, are not surrounded by fibrous tissue 
that protects against external compression, and, therefore, stricture and/or 
obstruction due to compression by regenerative nodules and/or fibrosis is 
more severe than that noted in portal veins in cirrhosis. Therefore, we 
thought that the disturbances of hepatic venous drainage present in 
cirrhosis might markedly affect hepatic morphology and found selective 
atrophy of the MHV drainage area in hepatitis C-related cirrhosis [14]. The 
possible causes of the selective volume reduction seen in the MHV drainage 
area were considered to be as follows: the length of the MHV is slightly 
shorter than that of the RHV, and the proximal diameter is the smallest 
among the three major hepatic veins in normal livers. In contrast, the total 
volume of the MVH drainage area is the largest among LHV, MHV and RHV 
drainage areas. As a result, the postsinusoidal pressure elevation in the 
MHV drainage area due to compression by regenerative nodules is expected 
to be larger than in the other areas [14].  
As revealed in this study, the most common site of confluent fibrosis exactly 
corresponded to the selective atrophic hepatic venous drainage area in 
cirrhosis. Therefore, confluent fibrosis may be explained as an extreme form 
of the selective atrophy of the MHV drainage area in cirrhosis, although this 
study included a variety of etiologies of cirrhosis. This is also strongly 
supported by the fact that the confluent fibrosis was more frequently found 
in advanced cirrhosis. In addition, the fact that all confluent fibrosis was 
located in the subcapsular area, radiating from the central portion of the 
liver to the hepatic periphery [4, 5] is also well explained by the larger 
resistance of hepatic venous drainage due to the relatively longer distance.  
Although fibrosis is a common change in cirrhosis, its histological pattern 
varies depending on the etiology of cirrhosis [3]. For example, fibrous septa 
bridging portal triads and central veins are often seen in viral 
infection–related cirrhosis. On the other hand, perivenular and 
perisinusoidal fibrosis is commonly seen in alcoholic cirrhosis, and 
cholestasis-induced liver injury shows biliary interface hepatitis including 
fibroplasia in the portal area [28]. Furthermore, so-call regenerative nodules 
in cirrhosis that are carved by progressive hepatic fibrous bands [2] are 
classified as macro-, micro-, and mixed-nodular cirrhosis, and also tends to 
depend on the etiologies of the cirrhosis [19]. However, as cirrhosis 
progresses, the characteristic histologic features of various etiologies may be 
lost, and the features of specific types of cirrhosis may be indistinguishable 
from cirrhosis due to other causes [2]. Thus, not only the differences of a 
variety of etiologies but also blood flow disorders may strongly influence 
confluent fibrosis. In addition, a histopathological study of the segmental 
atrophy of the liver suggested that the lesion was strongly associated with 
vascular injury [30].  
The characteristic imaging findings of fibrosis depending on the etiology of 
cirrhosis are also seen; for example, AIH shows mostly extensive reticular 
and/or confluent fibrosis [31], PBC frequently shows lace-like pattern 
fibrosis [32], and alcoholic cirrhosis occasionally shows confluent fibrosis [4] 
also demonstrated in this study. The distinct amount of histological fibrosis 
promoted by metabolic production of alcohol in alcoholic cirrhosis [33] may 
have some relation with the difference in the appearance of fibrosis. 
Therefore, the amount of fibrosis depending on specific etiologies may have a 
substantial influence on confluent fibrosis.     
Our study had several limitations. First, the diagnosis of cirrhosis was 
established with pathology in only two-thirds of the patients. Second, the 
diagnosis of confluent fibrosis was established by the imaging findings 
except for in the four patients who underwent liver transplantation or 
partial hepatectomy. Third, in some patients with cirrhosis classified as 
Child-Pugh class C, there was some difficulty with the identification of 
hepatic vessels because of low contrast between the liver parenchyma and 
hepatic vessels. The window level and width were adequately adjusted to 
detect the fine vessels.  
 
Conclusion  
Confluent fibrosis associated with liver cirrhosis was most commonly 
located in the MHV drainage area, and may have a relation to the hepatic 
venous drainage.   
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Figure legends  
Figure 1. 52-year-old man with alcoholic cirrhosis who is classified as 
Child-Pugh class B.   
a Pre-contrast CT image shows a wedge-shaped low attenuation area 
accompanied by capsule retraction and volume loss, which was defined as 
confluent fibrosis (arrowhead).  
b Arterial phase CT image shows less marked enhancement of the lesion 
than that of adjacent hepatic parenchyma (arrowhead).  
c Portal Phase CT image shows trapped branches of P8 and P4 within 
confluent fibrosis (arrowhead). The lesion was located at the boundary 
between anterior and medial segments.  
d Equilibrium-phase CT image shows trapped branches of MHV within 
confluent fibrosis (arrowhead). The lesion was located in MHV drainage 
area.  
 
Figure 2. 67-year-old man with alcoholic cirrhosis who is classified as 
Child-Pugh class B.  
a Pre-contrast CT image shows a wedge-shaped low attenuation area 
accompanied by capsule retraction and volume loss, which was defined as 
confluent fibrosis (arrowhead).  
b Arterial phase CT image shows early enhancement of the lesion 
(arrowhead).  
c Portal Phase CT image shows trapped branches of P8 and P4 within 
confluent fibrosis (arrowhead). The lesion was located at the boundary 
between anterior and medial segments.  
d Equilibrium-phase CT image shows branches of MHV trapped within 






Tables   
Table 1 Causes of liver cirrhosis and more details in 879 patients. 
 
Table 2 Results of univariable analyses and stepwise multiple logistic 
regression analysis.  
Stepwise multivariate logistic regression analysis included the variables 
which were significant in the univariable analyses. The results showed that 
the significant predictive factors of confluent fibrosis were alcoholic cirrhosis, 
Child-Pugh class C, and Child-Pugh class B.  
 
Table 3 Location of confluent hepatic fibrosis in terms of portal venous 
supply.  
The goodness-of-fit test showed the unequal distribution of the location of 
confluent fibrosis (χ25 = 28.26, P < .0001; the last three locations [n=1] were 
categorized as others). The confluent fibrosis was most commonly seen at the 
boundary between the medial and anterior segments.    
 Table 4 Location of confluent hepatic fibrosis in terms of hepatic venous 
drainage.  
The goodness-of-fit test showed the unequal distribution of the location of 
confluent fibrosis (χ23 = 24.77, P < .0001). The confluent fibrosis was most 
commonly seen in MHV drainage area.   

























virus infection 528 
303/22
5 67.8 ± 9.8 399 85 44 
Hepatitis B 
virus infection 122 91/31 61.4 ± 9.2  87 27 8 
Alcoholism 114 97/17 62.2 ± 10.5 74 27 13 
Unknown 
etiology  36 15/21 68.6 ± 12.1 21 9 6 
PBC 31 9/22 68.2 ± 9.1 19 3 9 
NASH 24 12/12 64.0 ± 12.3 20 3 1 
AIH 15 4/11 64.9 ± 13.2 8 5 2 
Hepatitis C and 
B virus 
infection 
3 2/1 61.7 ± 11.6 2 0 1 
Budd-Chiari 




2 2/0 60.5 ± 12.5 1 1 0 
Wilson’s 
disease 1 1/0 7.0 ± 0.0 0 0 1 
Table 2 Results of univariable analyses and stepwise multiple logistic 
regression analysis.   
 
 
Stepwise multivariate logistic regression analysis included the variables 
that were significant in the univariable analyses. The significant predictive 
factors of confluent fibrosis were alcoholic cirrhosis, Child-Pugh class C, and 








Multiple logistic regression 
analysis 





cases (n=879) 30 849 - - 
Male/Female 24/6 515/334 0.036 0.167 - - 
Age 62.6±10.3 
66.1± 










9 152 .023 2.914 1.161-7.312  
Child-Pugh 




hers 17/13 97/752 .0001 .0001 7.251 
3.366-15.6
19  
Table 3 Location of confluent hepatic fibrosis in terms of portal venous 

























The goodness-of-fit test showed the unequal distribution of the location of 
confluent fibrosis (χ25 = 28.26, P < .0001; the last three locations [n=1] were 
categorized as others). The confluent fibrosis was most commonly seen at the 
boundary between the medial and anterior segments.   
Location Number of Lesions  
Medial and anterior segments  
(boundary between the 
medial and anterior 
segments) 
17 
Anterior segment  7  
Anterior and posterior 
segments  
3 
Lateral segment  3 
Medial, anterior and 
posterior segments  
         2 
Medial segment  1 
Posterior segment  1 
Lateral, medial, and anterior 
segments  
1 
Total (n=35) 35 











The goodness-of-fit test showed the unequal distribution of the location of 
confluent fibrosis (χ23 = 24.77, P < .0001). The confluent fibrosis was most 
commonly seen in MHV drainage area.   
 
Location Number of Lesions  
MHV drainage area  21 
RHV drainage area 8  
LHV drainage area 3  
MHV and RHV areas 3 
Total 35 


